The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Isolation of Phages for Phage Therapy: A Comparison of Spot Tests and Efficiency of Plating Analyses for Determination of Host Range and Efficacy
Open accessAbstract
Phage therapy, treating bacterial infections with bacteriophages, could be a future alternative to antibiotic treatment of bacterial infections. There are, however, several problems to be solved, mainly associated to the biology of phages, the interaction between phages and their bacterial hosts, but also to the vast variation of pathogenic bacteria which implies that large numbers of different phages are going to be needed. All of these phages must under present regulation of medical products undergo extensive clinical testing before they can be applied. It will consequently be of great economic importance that effective and versatile phages are selected and collected into phage libraries, i.e., the selection must be carried out in a way that it results in highly virulent phages with broad host ranges. We have isolated phages using the Escherichia coli reference (ECOR) collection and compared two methods, spot testing and efficiency of plating (EOP), which are frequently used to identify phages suitable for phage therapy. The analyses of the differences between the two methods show that spot tests often overestimate both the overall virulence and the host range and that the results are not correlated to the results of EOP assays. The conclusion is that single dilution spot tests cannot be used for identification and selection of phages to a phage library and should be replaced by EOP assays. The difference between the two methods can be caused by many factors. We have analysed if the differences and lack of correlation could be caused by lysis from without, bacteriocins in the phage lysate, or by the presence of prophages harbouring genes coding for phage resistance systems in the genomes of the bacteria in the ECOR collection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
STUDIES ON LYSOGENESIS I: The Mode of Phage Liberation by Lysogenic Escherichia coli
Bertani, G. (1951) · Journal of Bacteriology · doi:10.1128/jb.62.3.293-300.1951 · Cited by 3,171
Phage treatment of human infections
Abedon, S. T., Kuhl, S. J., Blasdel, B. G., & Kutter, E. M. (2011) · Bacteriophage · doi:10.4161/bact.1.2.15845 · Cited by 980
Bacteriophage Host Range and Bacterial Resistance
Hyman, P., & Abedon, S. T. (2010) · Advances in Applied Microbiology · doi:10.1016/s0065-2164(10)70007-1 · Cited by 819
Standard reference strains of Escherichia coli from natural populations
Ochman, H., & Selander, R. K. (1984) · Journal of Bacteriology · doi:10.1128/jb.157.2.690-693.1984 · Cited by 807
Phage Therapy in Clinical Practice: Treatment of Human Infections
Kutter, E., De Vos, D., Gvasalia, G., Alavidze, Z., Gogokhia, L., Kuhl, S., & Abedon, S. (2010) · Current Pharmaceutical Biotechnology · doi:10.2174/138920110790725401 · Cited by 670
Phage Host Range and Efficiency of Plating
Kutter, E. (2009) · Methods in Molecular Biology · doi:10.1007/978-1-60327-164-6_14 · Cited by 558
Phage Choice, Isolation, and Preparation for Phage Therapy
Gill, J., & Hyman, P. (2010) · Current Pharmaceutical Biotechnology · doi:10.2174/138920110790725311 · Cited by 441
Abedon, S. T. (2011) · Bacteriophage · doi:10.4161/bact.1.1.13980 · Cited by 410
Frequency of morphological phage descriptions in the year 2000
Ackermann, H.-W. (2001) · Archives of Virology · doi:10.1007/s007050170120 · Cited by 340
Practical Methods for Determining Phage Growth Parameters
Hyman, P., & Abedon, S. T. (2009) · Methods in Molecular Biology · doi:10.1007/978-1-60327-164-6_18 · Cited by 327
The Phage Therapy Paradigm: Prêt-à-Porter or Sur-mesure?
Pirnay, J.-P., De Vos, D., Verbeken, G., Merabishvili, M., Chanishvili, N., Vaneechoutte, M., Zizi, M., Laire, G., Lavigne, R., Huys, I., et al. (2011) · Pharmaceutical Research · doi:10.1007/s11095-010-0313-5 · Cited by 298
(2006) · Encyclopedia of Entomology · doi:10.1007/0-306-48380-7_2066 · Cited by 295
Abedon, S., & Thomas-Abedon, C. (2010) · Current Pharmaceutical Biotechnology · doi:10.2174/138920110790725410 · Cited by 284
Phage therapy—constraints and possibilities
Nilsson, A. S. (2014) · Upsala Journal of Medical Sciences · doi:10.3109/03009734.2014.902878 · Cited by 206
Self-citationSalmonella reference collection B (SARB): strains of 37 serovars of subspecies I
Boyd, E. F., Wang, F.-S., Beltran, P., Plock, S. A., Nelson, K., & Selander, R. K. (1993) · Journal of General Microbiology · doi:10.1099/00221287-139-6-1125 · Cited by 201
Working with bacteriophages: common techniques and methodological approaches
Carlson, K. (2005) · Cited by 160
Riley, M. A., & Gordon, D. M. (1992) · Journal of General Microbiology · doi:10.1099/00221287-138-7-1345 · Cited by 159
Phage Therapy as an Approach to Prevent Vibrio anguillarum Infections in Fish Larvae Production
Silva, Y. J., Costa, L., Pereira, C., Mateus, C., Cunha, Â., Calado, R., Gomes, N. C. M., Pardo, M. Á., Hernández, I., & Almeida, A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0114197 · Cited by 158
Reference collection of strains of the Salmonella typhimurium complex from natural populations
Beltran, P. J., Plock, S. A., Smith, N. H., Whittam, T. S., Old, D. C., & Selander, R. K. (1991) · Journal of General Microbiology · doi:10.1099/00221287-137-3-601 · Cited by 157
Frampton, R. A., Taylor, C., Moreno, A. V. H., Visnovsky, S. B., Petty, N. K., Pitman, A. R., & Fineran, P. C. (2014) · Applied and Environmental Microbiology · doi:10.1128/aem.00062-14 · Cited by 142
Isolation and characterization of lytic bacteriophages against enterohaemorrhagic Escherichia coli
Viazis, S., Akhtar, M., Feirtag, J. M., Brabban, A. D., & Diez‐Gonzalez, F. (2011) · Journal of Applied Microbiology · doi:10.1111/j.1365-2672.2011.04989.x · Cited by 120
Call for a Dedicated European Legal Framework for Bacteriophage Therapy
Verbeken, G., Pirnay, J., Lavigne, R., Jennes, S., Vos, D. D., Casteels, M., & Huys, I. (2014) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-014-0269-y · Cited by 107
Bourdin, G., Navarro, A., Sarker, S. A., Pittet, A. C., Qadri, F., Sultana, S., Cravioto, A., Talukder, K. A., Reuteler, G., & Brüssow, H. (2014) · Microbial Biotechnology · doi:10.1111/1751-7915.12113 · Cited by 87
Comparison of Several Methods for Preserving Bacteriophages
Clark, W. A. (1962) · Applied Microbiology · doi:10.1128/am.10.5.466-471.1962 · Cited by 81
Kim, M., Kim, S., Park, B., & Ryu, S. (2013) · Applied and Environmental Microbiology · doi:10.1128/aem.03494-13 · Cited by 74
Tsonos, J., Oosterik, L. H., Tuntufye, H. N., Klumpp, J., Butaye, P., Greve, H. D., Hernálsteens, J.-P., Lavigne, R., & Goddeeris, B. M. (2013) · Veterinary Microbiology · doi:10.1016/j.vetmic.2013.10.021 · Cited by 64
Mirzaei, M. K., Eriksson, H., Kasuga, K., Haggård‐Ljungquist, E., & Nilsson, A. S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0116294 · Cited by 49
Self-citationOdegrip, R., Nilsson, A. S., & Haggård‐Ljungquist, E. (2006) · Journal of Bacteriology · doi:10.1128/jb.188.4.1643-1647.2006 · Cited by 38
Self-citationPieroni, P., Rennie, R. P., Ziola, B. R., & Deneer, H. G. (1994) · Journal of Medical Microbiology · doi:10.1099/00222615-41-6-423 · Cited by 32
Mosig, G., Yu, S. S. B., Myung, H., Haggård‐Ljungquist, E., Davenport, L., Carlson, K., & Calendar, R. L. (1997) · Virology · doi:10.1006/viro.1997.8464 · Cited by 29
Matsushita, K., Uchiyama, J., Kato, S.-I., Ujihara, T., Hoshiba, H., Sugihara, S., Muraoka, A., Wakiguchi, H., & Matsuzaki, S. (2008) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2008.01455.x · Cited by 27
Nilsson, A. S., & Haggård‐Ljungquist, E. (2005) · doi:10.1093/oso/9780195168778.003.0025 · Cited by 26
Self-citation(2014) · Journal of Phylogenetics & Evolutionary Biology · doi:10.4172/2329-9002.1000136 · Cited by 21
Editorial Commentary: Phage Therapy: Quo Vadis?
Brüssow, H. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit776 · Cited by 10
Cited by
Phages for Phage Therapy: Isolation, Characterization, and Host Range Breadth
Hyman, P. (2019) · Pharmaceuticals · doi:10.3390/ph12010035 · Cited by 546
Ménage à trois in the human gut: interactions between host, bacteria and phages
Mirzaei, M. K., & Maurice, C. F. (2017) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2017.30 · Cited by 403
More Is Better: Selecting for Broad Host Range Bacteriophages
Ross, A., Ward, S., & Hyman, P. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.01352 · Cited by 367
Phages and their potential to modulate the microbiome and immunity
Federici, S., Nobs, S. P., & Elinav, E. (2021) · Cellular & Molecular Immunology · doi:10.1038/s41423-020-00532-4 · Cited by 222
Bacteriophage Therapy: Discovery, Development, and FDA Approval Pathways
Niazi, S. K. (2025) · Pharmaceuticals · doi:10.3390/ph18081115 · Cited by 56
Metadata
- Authors
- Khan Mirzaei, M., & Nilsson, A. S.
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2015-03-11
- Volume
- 10
- Issue
- 3
- Pages
- e0118557
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2068345774
- Cited by
- 516
- References
- 34
- FWCI
- 19.52
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.